Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTAX01 for Complex Diabetic Foot Ulcers
NCT04176120Phase 3Completed
- Sponsor
- BioTissue
- Start
- Jul 2020
- Primary completion
- Jan 2024
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of TTAX01 in diabetic foot ulcer (DFU), sponsored by BioTissue. Started Jul 2020; status: completed.
02
Drugs
TTAX01
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04176120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176120.